AMAL TANAGHO: Open Payments
NPI 1154538023 · HUNTINGTON BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,809 in 80 payments from 13 companies in 2025. Trend: 2023 $2,343 · 2024 $1,593 · 2025 $1,809
Food & beverage: $1,809
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $389 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $229 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $211 |
| Lundbeck LLC | 8 | $208 |
| Vanda Pharmaceuticals Inc. | 8 | $193 |
| Axsome Therapeutics, Inc. | 12 | $173 |
| Bausch Health US, LLC | 7 | $141 |
| Otsuka America Pharmaceutical, Inc. | 3 | $98 |
| Neos Therapeutics, LP | 4 | $69 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
Products named: VRAYLAR, REXULTI, TRINTELLIX, CAPLYTA, FANAPT, Auvelity, APLENZIN, Adzenys XR-ODT.
Industry payments across CA — which companies pay providers there.
